As both a clinician and a scientist, Fox is particularly interested in using the network approach not only to better understand particular diseases, but also to treat them. He has spent years working to optimize brain-stimulation treatments for diseases like Parkinsons and depression. The two primary approaches to brain stimulationdeep brain stimulation (DBS), which involves surgically implanting wires directly into the brain, and transcranial magnetic stimulation (TMS), a noninvasive approach that involves passing a magnet over specific locations on the skullwere both available when Fox began his work in the first decade of the 2000s, but they were far from being perfected.

Both technologies are based on the idea that some neurological and psychiatric diseases are caused by abnormal brain activity, and stimulation may be able to correct them. In Parkinsons, stimulating an area called the basal ganglia relieves symptoms like tremor, and a closely related technology called responsive neurostimulation can quell epileptic seizures by targeting where they originate. As an electrical engineer, the idea that you could stick electrodes in someones brain, turn them on, and have almost miracle-like effects on Parkinsons symptomsor hold an electromagnet over somebodys brain and fix their depressionit almost seemed like science fiction, he says.

But decades of research have proven that, for most other diseases, such regions dont exist. And even if they did, stimulation to a specific spot is not going to remain confined to that spot, because an activated brain region will send out signals along white matter tracts, and those signals may in turn activate other regions. If you want to stimulate [a] particular area of the brain to quiet a seizure, your stimulation to that region doesnt stay in the regionit goes everywhere else, Bassett says.

Along with giving clinicians a better understanding of the consequences of brain stimulation, network neuroscience may also help scientists design better techniques. In particular, if scientists can determine the circuits that a highly invasive technique like deep brain stimulation is acting upon, they might be able to achieve similar results with a nonsurgical approach like TMS. Once your target is a circuit, you can target that circuit in different ways, Fox says. You could begin to test the therapeutic effect of the circuit noninvasively before you do something invasive. In particular, this approach could allow clinicians to access regions buried in the brain, like those targeted in DBS treatments for Parkinsons, through areas closer to the surface. If those regions are connected to more superficial regions, then perhaps, with this network understanding, you can figure out which region is connected in the best way to the target region so that TMS will be effective, Vrtes says.

And as scientists start thinking of brain diseases as the results of multiple regions acting in concert, as opposed to single regions, they can start trying to target the whole circuit at once. It might be that the best way to help a symptom that maps to a circuit is actually multiple electrodes, or multiple stimulation sites, Fox says.

Pharmacological treatments, which dominate psychiatric practice, dont only affect specific brain areas. Just like a painkiller will lessen pain throughout the body, so too will a psychiatric medication spread throughout the brain. Nevertheless, network neuroscience could still prove useful for optimizing drug regimens: It could help clinicians target their choice of drug to the individual, not the disease. If scientists better understand what makes each brain different, they may be able to leverage those differences to predict who will respond best to which drug.

For some people, drug X works, and for some other people, drug Y works, and you dont know until you try them both, Bassett says. And I feel like its medieval science. But hopefully, with an understanding of the individual differences in the brain, we will have a better lever on how to predict human responses to a particular interventionand then not have to have people go for a year through different kinds of medication before we find one that works for them.

View original post here:
A Radical New Model of the Brain Illuminates Its Wiring - WIRED